Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab.
Seban RD, Arnaud E, Loirat D, Cabel L, Cottu P, Djerroudi L, Hescot S, Loap P, Bonneau C, Bidard FC, Huchet V, Jehanno N, Berenbaum A, Champion L, Buvat I. Seban RD, et al. Among authors: berenbaum a. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4024-4035. doi: 10.1007/s00259-023-06394-y. Epub 2023 Aug 22. Eur J Nucl Med Mol Imaging. 2023. PMID: 37606858
Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settings.
Soret M, Maisonobe JA, Desarnaud S, Bergeret S, Causse-Lemercier V, Berenbaum A, Rozenblum L, Habert MO, Kas A. Soret M, et al. Among authors: berenbaum a. Sci Rep. 2022 Sep 12;12(1):15341. doi: 10.1038/s41598-022-18029-7. Sci Rep. 2022. PMID: 36097015 Free PMC article.
Hybrid [18F]-F-DOPA PET/MRI Interpretation Criteria and Scores for Glioma Follow-up After Radiotherapy.
Bertaux M, Berenbaum A, Di Stefano AL, Rozenblum L, Soret M, Bergeret S, Hoang-Xuan K, Tainturier LE, Sgard B, Habert MO, Delattre JY, Dehais C, Idbaih A, Pyatigorskaya N, Kas A. Bertaux M, et al. Among authors: berenbaum a. Clin Neuroradiol. 2022 Sep;32(3):735-747. doi: 10.1007/s00062-022-01139-0. Epub 2022 Feb 11. Clin Neuroradiol. 2022. PMID: 35147721
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors.
Seban RD, Mezquita L, Berenbaum A, Dercle L, Botticella A, Le Pechoux C, Caramella C, Deutsch E, Grimaldi S, Adam J, Ammari S, Planchard D, Leboulleux S, Besse B. Seban RD, et al. Among authors: berenbaum a. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1147-1157. doi: 10.1007/s00259-019-04615-x. Epub 2019 Nov 21. Eur J Nucl Med Mol Imaging. 2020. PMID: 31754795